Association between neutrophil percentage-to-albumin ratio and bone mineral density and prevalent osteoporosis in patients with type 2 diabetes mellitus - Report - MDSpire
Advertisement
Association between neutrophil percentage-to-albumin ratio and bone mineral density and prevalent osteoporosis in patients with type 2 diabetes mellitus
Clinical Report: Relationship of Neutrophil Percentage-to-Albumin Ratio with Bone Mineral Density
Overview
This study investigates the association between the neutrophil percentage-to-albumin ratio (NPAR) and bone mineral density (BMD) in patients with type 2 diabetes mellitus (T2DM). Higher NPAR levels were found in individuals with osteoporosis, and NPAR was independently associated with osteoporosis and negatively correlated with BMD.
Background
Patients with type 2 diabetes mellitus (T2DM) are at an increased risk of osteoporosis and fragility fractures, despite often having normal or elevated bone mineral density (BMD). Chronic low-grade inflammation and nutritional imbalance are key mechanisms contributing to this risk.
Data Highlights
Parameter
Result
NPAR levels in osteoporosis group
Higher (P = 0.004)
NPAR and osteoporosis association
OR = 3.42 (95% CI: 1.10-10.64, P = 0.034)
Femoral neck BMD correlation
b = -0.08 (95% CI: -0.14 to -0.02, P = 0.009)
Total hip BMD correlation
b = -0.08 (95% CI: -0.14 to -0.01, P = 0.020)
AUC for osteoporosis discrimination
0.62 (95% CI: 0.54-0.71, P = 0.004)
Key Findings
NPAR levels were significantly higher in patients with osteoporosis (P = 0.004).
NPAR was independently associated with osteoporosis (OR = 3.42, P = 0.034).
Negative correlation between NPAR and femoral neck BMD (b = -0.08, P = 0.009).
Negative correlation between NPAR and total hip BMD (b = -0.08, P = 0.020).
NPAR demonstrated a modest discriminative ability for prevalent osteoporosis (AUC = 0.62, P = 0.004).
Clinical Implications
NPAR should be interpreted in combination with other clinical indicators for a comprehensive evaluation.
Conclusion
The study presents findings on the association between NPAR and osteoporosis risk among patients with T2DM.